Pharmaceutical Logistics Market (By Type: Cold Chain Logistics and Non-cold Chain Logistics; By Component: Storage and Transportation) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

The global pharmaceutical logistics market size was exhibited at USD 84.39 billion in 2022 and is projected to hit around USD 189.05 billion by 2032, growing at a CAGR of 8.4% during the forecast period 2023 to 2032.

pharmaceutical logistics market size

Key Pointers:

  • In terms of value, cold chain logistics segment is anticipated to hold a considerate market share by 2032 and is expected to grow at significant growth rate from 2023 to 2032.
  • The storage segment attained the largest market share of more than 63.19% in 2022. 
  • The monitoring components segment is expected to witness the highest CAGR from 2023 to 2032
  • Europe accounted for a market share of over 36.9% in 2022
  • The Asia Pacific region is projected to be the fastest-growing region

Pharmaceutical Logistics Market Report Scope

Report Coverage

Details

Market Size in 2023

USD 91.48 Billion

Market Size by 2032

USD 189.05 Billion

Growth Rate From 2023 to 2032

CAGR of 8.4%

Base Year

2022

Forecast Period

2023 to 2032

Segments Covered

Type, Component, Application, Procedure

Market Analysis (Terms Used)

Value (US$ Million/Billion) or (Volume/Units)

Regional Scope

North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa

Key Companies Profiled

FedEx, Agility, CEVA Logistics, Deutsche Post AG, VersaCold Logistics Services, LifeConEx, Air Canada, United Parcel Service of America Inc., DB Schenker, Marken.

 

The market growth is primarily driven by the rising demand for a variety of drugs as a result of increasing cases of chronic and lifestyle-related diseases. The market is expected to witness a high growth rate in cold-chain and non-cold chain pharmaceutical logistics owing to the impact of COVID-19 across the globe. During this pandemic situation, the government and officials across countries are primarily focusing on preventive measures and the treatment of patients. The import and export of various medicines to treat coronavirus are increasing across all countries, including U.S. and China.

Along with international trade, the nationwide logistics of drugs are also expected to increase to fulfill the rising demand from all the hospitals and medical establishments. Additionally, the U.S. Food and Drug Administration (FDA) and other healthcare agencies across various countries, such as India, China, and the U.K. approved the emergency use of COVID-19 vaccines. This, in turn, is expected to increase the global trade of vaccines in many countries, including the U.S. and India. Such increased trade of drugs and medicines across countries is expected to drive the market from 2023 to 2030.

Pharmaceutical logistics is an integral part of the healthcare system, as careful handling and transportation of pharmaceutical products are of utmost importance. Therefore, the equipment and staff services involved in the pharma supply chain are highly expensive. The latest trend gaining momentum in the market is consolidation among the pharma companies to expand their business and global presence. Technological advancements, such as cloud-based supply chain functions and blockchain technology, which provide accurate and real-time data of operations, will also have a positive impact on market growth. Additionally, these technologies also offer predictive analytics to identify demand and supply chain optimization and risk management. Identifying risks and preventing them helps companies increase productivity, efficiency, and process optimization of their businesses.

The market in Asia Pacific is projected to exhibit the highest CAGR from 2023 to 2032 owing to an increasing financial budget for the healthcare sector in several emerging countries of the region. Additionally, the soaring consumer spending in Over the Counter (OTC) pharmaceutical products is further boost the regional market growth over the forecast period.

Some of the prominent players in the Pharmaceutical Logistics Market include:

  • FedEx
  • Agility
  • CEVA Logistics
  • Deutsche Post AG
  • VersaCold Logistics Services
  • LifeConEx
  • Air Canada
  • United Parcel Service of America Inc.
  • DB Schenker
  • Marken

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Pharmaceutical Logistics market.

By Type

  • Cold Chain Logistics
  • Non-cold Chain Logistics

By Component

  • Storage
    • Warehouse
    • Refrigerated container
  • Transportation
    • Sea freight Logistics
    • Airfreight Logistics
    • Overland Logistics
  • Monitoring components
    • Hardware
      • Sensors
      • RFID Devices
      • Telematics
      • Networking Devices
    • Software

By Application

  • Bio Pharma
  • Chemical Pharma
  • Speciality Pharma

By Procedure

  • Picking
  • Storage
  • Retrieval Systems
  • Handling Systems

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global pharmaceutical logistics market size was exhibited at USD 84.39 billion in 2022 and is projected to hit around USD 189.05 billion by 2032

The growing demand for the overthecounter (OTC) medicines such as supplements, minerals, vitamins, common cough, gastrointestinal pharmaceuticals, and cold remedies products is also contributing to the expansion of the pharmaceutical logistics industry.

Some of the prominent players in the global pharmaceutical logistics market include FedEx, Agility, CEVA Logistics, Deutsche Post AG, VersaCold Logistics Services, LifeConEx, Air Canada, United Parcel Service of America Inc., DB Schenker, Marken.

Europe is the largest segment for pharmaceutical logistics market in terms of region. The significant growth in the pharmaceutical product trade across key European countries is responsible for the high market share.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Pharmaceutical Logistics Market 

5.1. COVID-19 Landscape: Pharmaceutical Logistics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Pharmaceutical Logistics Market, By Type

8.1. Pharmaceutical Logistics Market, by Type, 2023-2032

8.1.1. Cold Chain Logistics

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Non-cold Chain Logistics

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Pharmaceutical Logistics Market, By Component

9.1. Pharmaceutical Logistics Market, by Component, 2023-2032

9.1.1. Storage

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Transportation

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Monitoring components

9.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Pharmaceutical Logistics Market, By Application Type 

10.1. Pharmaceutical Logistics Market, by Application Type, 2023-2032

10.1.1. Bio Pharma

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Chemical Pharma

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Speciality Pharma

10.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Pharmaceutical Logistics Market, By Procedure Type 

11.1. Pharmaceutical Logistics Market, by Procedure Type, 2023-2032

11.1.1. Picking

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Storage

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Retrieval Systems

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Handling Systems

11.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Pharmaceutical Logistics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2020-2032)

12.1.2. Market Revenue and Forecast, by Component (2020-2032)

12.1.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.1.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Component (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.1.5.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Component (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.1.6.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.2. Market Revenue and Forecast, by Component (2020-2032)

12.2.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.2.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Component (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.2.5.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Component (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.2.6.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Component (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.2.7.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Component (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.2.8.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.2. Market Revenue and Forecast, by Component (2020-2032)

12.3.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.3.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Component (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.3.5.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Component (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.3.6.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Component (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.3.7.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Component (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.3.8.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.2. Market Revenue and Forecast, by Component (2020-2032)

12.4.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.4.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Component (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.4.5.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Component (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.4.6.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Component (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.4.7.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Component (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.4.8.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.5.2. Market Revenue and Forecast, by Component (2020-2032)

12.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.5.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Component (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.5.5.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Component (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.5.6.4. Market Revenue and Forecast, by Procedure Type (2020-2032)

Chapter 13. Company Profiles

13.1. FedEx

13.1.1. Company Overview

13.1.2. Product Offering

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Agility

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. CEVA Logistics

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Deutsche Post AG

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. VersaCold Logistics Services

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. LifeConEx

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Air Canada

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. United Parcel Service of America Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. DB Schenker

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Marken

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers